Semaglutide has been available for several years as a once-weekly injection, but the new oral formulation represents an important milestone
The content herein is not intended to be, act as, or replace medical advice or diagnosis for individual health conditions nor is it making evaluations as to the risks or benefits of particular preparations
Lawsuits filed against businesses selling compounded injectables for diabetes and weight-loss Novo Nordisk and Eli Lilly, who developed and won FDA approval for their blockbuster weight-loss and diabetes medicines, Ozempic, Wegovy, Mounjaro and Zepbound, have been suing businesses who they say are marketing compounded versions of these drugs with false claims
The gastrointestinal effects typically emerge during dose escalation and may diminish with continued use as physiologic adaptation occurs
How to Interpret the Evidence Clinically Even with consistent observational associations, several points remain critical: Confounding remains likely
What do chapped lips say about your health